Kenneth C. Cundy, SVP, Preclinical Development at XENOPORT INC (XNPT), sold 1,000 shares at $22.00 ($22K) on 2009-10-06, disclosed to the SEC on 2009-10-07.
Scheduled sale ($22k) by SVP, Preclinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 100 | $2K | 10.0% |
| 2 | $22.00 | 900 | $20K | 90.0% |
| Total | $22.00 avg | 1,000 | $22K | 100% |
| Filing → |
| CWBR | SELL | 2020-08-10 | $19K | — | Filing → |
| CWBR | SELL | 2020-06-17 | $24K | — | Filing → |
| CWBR | SELL | 2020-05-18 | $26K | — | Filing → |